McClay, J. L., Vunck, S. A., Batman, A. M., Crowley, J. J., Vann, R. E., Beardsley, P. M., & van den Oord, E. J. (2015). Neurochemical metabolomics reveals disruption to sphingolipid metabolism following chronic haloperidol administration. J Neuroimmune Pharmacol.
Citação norma ChicagoMcClay, Joseph L., Sarah A. Vunck, Angela M. Batman, James J. Crowley, Robert E. Vann, Patrick M. Beardsley, and Edwin J. van den Oord. "Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration." J Neuroimmune Pharmacol 2015.
Citação norma MLAMcClay, Joseph L., et al. "Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration." J Neuroimmune Pharmacol 2015.